Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease'. Together they form a unique fingerprint.

Medicine & Life Sciences